Khaya Biosciences, Inc.
New Form D on file · 2026-08-13 · the record
What the record says
Trailing twelve months. 716 filings in Biotechnology, totalled by week. The dot is this raise, $200K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Use of proceeds, as written on the filing
Estimate to pay the CEO's salary and wages, in line with the pro-forma projections shared with investors.
Company officers on record
Garcia Sebastian is named as Executive Officer and Director on the Form D that Khaya Biosciences, Inc. filed with the SEC on 13 August 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-08-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Khaya Biosciences, Inc.
- Source Check — verify Sebastian Garcia's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Sebastian Garcia for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Khaya Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Khaya Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.